NCT03588468View on ClinicalTrials.gov

Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 20, 2018

Primary Completion Date

December 18, 2019

Study Completion Date

December 18, 2019

Conditions
Amyloid NeuropathiesTransthyretin Amyloidosis
Interventions
OTHER

Electrophysiological biomarkers

Motor and sensory nerve conduction study will be performed on median, ulnar, tibialis, peroneal and sural nerves.

OTHER

MRI biomarkers

T1, T2, STIR and magnetisation transfer ratio (MTR) will be performed unilaterally on the thigh and the leg.

Trial Locations (1)

13354

Assistance Publique Des Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT03588468 - Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study | Biotech Hunter | Biotech Hunter